Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea

The authors have withdrawn this manuscript because of the controversy about hydroxychloroquine and potential changes in results after peer-review, the authors intend to share their results in formal publication. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author..

Medienart:

Preprint

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

bioRxiv.org - (2021) vom: 04. Jan. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

Kim, Min Seo [VerfasserIn]
Jang, Soon-Woo [VerfasserIn]
Park, Yu-Kyung [VerfasserIn]
Kim, Bong-Ok [VerfasserIn]
Hwang, Tae-Ho [VerfasserIn]
Kang, Seok Ho [VerfasserIn]
Kim, Won Jun [VerfasserIn]
Kyu, Park Sung [VerfasserIn]
Park, Hea-Woon [VerfasserIn]
Yang, Wonjong [VerfasserIn]
Jang, Joonyoung [VerfasserIn]
An, Min Ho [VerfasserIn]

Links:

Volltext [kostenfrei]

doi:

10.1101/2020.05.13.20094193

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XBI017920205